Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway

[1] Sung H(2021)Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49

[2] Ferlay J(2019)Non-small Cell Lung Cancer: Epidemiology, Screening, diagnosis, and treatment Mayo Clin Proc 94 1623-40

[3] Siegel RL(2014)Systems biology approaches to understanding epithelial mesenchymal transition (EMT) in mucosal remodeling and signaling in asthma World Allergy Organ J 7 13-25

[4] Laversanne M(2022)Targeted therapies for Lung Cancer patients with oncogenic driver molecular alterations J Clin Oncol 40 611-62

[5] Soerjomataram I(2019)Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations Br J Cancer 120 57-648

[6] Jemal A(2005)The structure and function of SMC and kleisin complexes Annu Rev Biochem 74 595-71

[7] Bray F(2016)Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma Cancer Res 76 4861-9

[8] Duma N(2008)hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature Am J Surg Pathol 32 205-6

[9] Santana-Davila R(2022)NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer J Exp Clin Cancer Res 41 198-80

[10] Molina JR(2004)ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 1-24

[1] Sung H(2021)Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49

[2] Ferlay J(2019)Non-small Cell Lung Cancer: Epidemiology, Screening, diagnosis, and treatment Mayo Clin Proc 94 1623-40

[3] Siegel RL(2014)Systems biology approaches to understanding epithelial mesenchymal transition (EMT) in mucosal remodeling and signaling in asthma World Allergy Organ J 7 13-25

[4] Laversanne M(2022)Targeted therapies for Lung Cancer patients with oncogenic driver molecular alterations J Clin Oncol 40 611-62

[5] Soerjomataram I(2019)Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations Br J Cancer 120 57-648

[6] Jemal A(2005)The structure and function of SMC and kleisin complexes Annu Rev Biochem 74 595-71

[7] Bray F(2016)Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma Cancer Res 76 4861-9

[8] Duma N(2008)hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature Am J Surg Pathol 32 205-6

[9] Santana-Davila R(2022)NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer J Exp Clin Cancer Res 41 198-80

[10] Molina JR(2004)ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 1-24